Global Malignant Lymphoma Market Size, Status and Forecast 2022

October 2017 | 108 pages | ID: G588A35DEA0EN
QYResearch

Abstracts

This report studies the global Malignant Lymphoma market, analyzes and researches the Malignant Lymphoma development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like

• Abbott Laboratories
• ABIOGEN PHARMA S.p.A
• Actelion Pharmaceuticals
• Aeterna Zentaris
• Allos Therapeutics
• Astellas Pharma
• Bristol-Myers Squibb Company
• Celgene Corporation
• Eli Lilly and Company
• Genmab
• Inovio Pharmaceuticals
• Johnson & Johnson
• Merck & Co
• Novartis
• Onyx Pharmaceuticals
• Roche
• Seattle Genetics

Market segment by Regions/Countries, this report covers

• United States
• EU
• Japan
• China
• India
• Southeast Asia

Market segment by Type, Malignant Lymphoma can be split into

• Hodgkin Lymphoma
• Non Hodgkin Lymphoma

Market segment by Application, Malignant Lymphoma can be split into

• Chemotherapy
• Radiation Therapy
• Immunotherapy
• Stem Cell Therapy
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Malignant Lymphoma Market Size, Status and Forecast 2022

1 INDUSTRY OVERVIEW OF MALIGNANT LYMPHOMA

1.1 Malignant Lymphoma Market Overview
  1.1.1 Malignant Lymphoma Product Scope
  1.1.2 Market Status and Outlook
1.2 Global Malignant Lymphoma Market Size and Analysis by Regions
  1.2.1 United States
  1.2.2 EU
  1.2.3 Japan
  1.2.4 China
  1.2.5 India
  1.2.6 Southeast Asia
1.3 Malignant Lymphoma Market by Type
  1.3.1 Hodgkin Lymphoma
  1.3.2 Non Hodgkin Lymphoma
1.4 Malignant Lymphoma Market by End Users/Application
  1.4.1 Chemotherapy
  1.4.2 Radiation Therapy
  1.4.3 Immunotherapy
  1.4.4 Stem Cell Therapy
  1.4.5 Others

2 GLOBAL MALIGNANT LYMPHOMA COMPETITION ANALYSIS BY PLAYERS

2.1 Malignant Lymphoma Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
  2.2.1 Market Concentration Rate
  2.2.2 Product/Service Differences
  2.2.3 New Entrants
  2.2.4 The Technology Trends in Future

3 COMPANY (TOP PLAYERS) PROFILES

3.1 Abbott Laboratories
  3.1.1 Company Profile
  3.1.2 Main Business/Business Overview
  3.1.3 Products, Services and Solutions
  3.1.4 Malignant Lymphoma Revenue (Value) (2012-2017)
  3.1.5 Recent Developments
3.2 ABIOGEN PHARMA S.p.A
  3.2.1 Company Profile
  3.2.2 Main Business/Business Overview
  3.2.3 Products, Services and Solutions
  3.2.4 Malignant Lymphoma Revenue (Value) (2012-2017)
  3.2.5 Recent Developments
3.3 Actelion Pharmaceuticals
  3.3.1 Company Profile
  3.3.2 Main Business/Business Overview
  3.3.3 Products, Services and Solutions
  3.3.4 Malignant Lymphoma Revenue (Value) (2012-2017)
  3.3.5 Recent Developments
3.4 Aeterna Zentaris
  3.4.1 Company Profile
  3.4.2 Main Business/Business Overview
  3.4.3 Products, Services and Solutions
  3.4.4 Malignant Lymphoma Revenue (Value) (2012-2017)
  3.4.5 Recent Developments
3.5 Allos Therapeutics
  3.5.1 Company Profile
  3.5.2 Main Business/Business Overview
  3.5.3 Products, Services and Solutions
  3.5.4 Malignant Lymphoma Revenue (Value) (2012-2017)
  3.5.5 Recent Developments
3.6 Astellas Pharma
  3.6.1 Company Profile
  3.6.2 Main Business/Business Overview
  3.6.3 Products, Services and Solutions
  3.6.4 Malignant Lymphoma Revenue (Value) (2012-2017)
  3.6.5 Recent Developments
3.7 Bristol-Myers Squibb Company
  3.7.1 Company Profile
  3.7.2 Main Business/Business Overview
  3.7.3 Products, Services and Solutions
  3.7.4 Malignant Lymphoma Revenue (Value) (2012-2017)
  3.7.5 Recent Developments
3.8 Celgene Corporation
  3.8.1 Company Profile
  3.8.2 Main Business/Business Overview
  3.8.3 Products, Services and Solutions
  3.8.4 Malignant Lymphoma Revenue (Value) (2012-2017)
  3.8.5 Recent Developments
3.9 Eli Lilly and Company
  3.9.1 Company Profile
  3.9.2 Main Business/Business Overview
  3.9.3 Products, Services and Solutions
  3.9.4 Malignant Lymphoma Revenue (Value) (2012-2017)
  3.9.5 Recent Developments
3.10 Genmab
  3.10.1 Company Profile
  3.10.2 Main Business/Business Overview
  3.10.3 Products, Services and Solutions
  3.10.4 Malignant Lymphoma Revenue (Value) (2012-2017)
  3.10.5 Recent Developments
3.11 Inovio Pharmaceuticals
3.12 Johnson & Johnson
3.13 Merck & Co
3.14 Novartis
3.15 Onyx Pharmaceuticals
3.16 Roche
3.17 Seattle Genetics

4 GLOBAL MALIGNANT LYMPHOMA MARKET SIZE BY TYPE AND APPLICATION (2012-2017)

4.1 Global Malignant Lymphoma Market Size by Type (2012-2017)
4.2 Global Malignant Lymphoma Market Size by Application (2012-2017)
4.3 Potential Application of Malignant Lymphoma in Future
4.4 Top Consumer/End Users of Malignant Lymphoma

5 UNITED STATES MALIGNANT LYMPHOMA DEVELOPMENT STATUS AND OUTLOOK

5.1 United States Malignant Lymphoma Market Size (2012-2017)
5.2 United States Malignant Lymphoma Market Size and Market Share by Players (2016 and 2017)

6 EU MALIGNANT LYMPHOMA DEVELOPMENT STATUS AND OUTLOOK

6.1 EU Malignant Lymphoma Market Size (2012-2017)
6.2 EU Malignant Lymphoma Market Size and Market Share by Players (2016 and 2017)

7 JAPAN MALIGNANT LYMPHOMA DEVELOPMENT STATUS AND OUTLOOK

7.1 Japan Malignant Lymphoma Market Size (2012-2017)
7.2 Japan Malignant Lymphoma Market Size and Market Share by Players (2016 and 2017)

8 CHINA MALIGNANT LYMPHOMA DEVELOPMENT STATUS AND OUTLOOK

8.1 China Malignant Lymphoma Market Size (2012-2017)
8.2 China Malignant Lymphoma Market Size and Market Share by Players (2016 and 2017)

9 INDIA MALIGNANT LYMPHOMA DEVELOPMENT STATUS AND OUTLOOK

9.1 India Malignant Lymphoma Market Size (2012-2017)
9.2 India Malignant Lymphoma Market Size and Market Share by Players (2016 and 2017)

10 SOUTHEAST ASIA MALIGNANT LYMPHOMA DEVELOPMENT STATUS AND OUTLOOK

10.1 Southeast Asia Malignant Lymphoma Market Size (2012-2017)
10.2 Southeast Asia Malignant Lymphoma Market Size and Market Share by Players (2016 and 2017)

11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)

11.1 Global Malignant Lymphoma Market Size (Value) by Regions (2017-2022)
  11.1.1 United States Malignant Lymphoma Revenue and Growth Rate (2017-2022)
  11.1.2 EU Malignant Lymphoma Revenue and Growth Rate (2017-2022)
  11.1.3 Japan Malignant Lymphoma Revenue and Growth Rate (2017-2022)
  11.1.4 China Malignant Lymphoma Revenue and Growth Rate (2017-2022)
  11.1.5 India Malignant Lymphoma Revenue and Growth Rate (2017-2022)
  11.1.6 Southeast Asia Malignant Lymphoma Revenue and Growth Rate (2017-2022)
11.2 Global Malignant Lymphoma Market Size (Value) by Type (2017-2022)
11.3 Global Malignant Lymphoma Market Size by Application (2017-2022)

12 MALIGNANT LYMPHOMA MARKET DYNAMICS

12.1 Malignant Lymphoma Market Opportunities
12.2 Malignant Lymphoma Challenge and Risk
  12.2.1 Competition from Opponents
  12.2.2 Downside Risks of Economy
12.3 Malignant Lymphoma Market Constraints and Threat
  12.3.1 Threat from Substitute
  12.3.2 Government Policy
  12.3.3 Technology Risks
12.4 Malignant Lymphoma Market Driving Force
  12.4.1 Growing Demand from Emerging Markets
  12.4.2 Potential Application

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
  13.3.1 Economic Fluctuations
  13.3.2 Other Risk Factors

14 RESEARCH FINDING/CONCLUSION

15 APPENDIX

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Malignant Lymphoma Product Scope
Figure Global Malignant Lymphoma Market Size (Million USD) (2012-2017)
Table Global Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Malignant Lymphoma Market Share by Regions in 2016
Figure United States Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Malignant Lymphoma Market Share by Type in 2016
Figure Hodgkin Lymphoma Market Size (Million USD) and Growth Rate (2012-2017)
Figure Non Hodgkin Lymphoma Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Malignant Lymphoma Market Share by Application in 2016
Table Key Downstream Customer in Chemotherapy
Figure Malignant Lymphoma Market Size (Million USD) and Growth Rate in Chemotherapy (2012-2017)
Table Key Downstream Customer in Radiation Therapy
Figure Malignant Lymphoma Market Size (Million USD) and Growth Rate in Radiation Therapy (2012-2017)
Table Key Downstream Customer in Immunotherapy
Figure Malignant Lymphoma Market Size (Million USD) and Growth Rate in Immunotherapy (2012-2017)
Table Key Downstream Customer in Stem Cell Therapy
Figure Malignant Lymphoma Market Size (Million USD) and Growth Rate in Stem Cell Therapy (2012-2017)
Table Key Downstream Customer in Others
Figure Malignant Lymphoma Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Malignant Lymphoma Market Size (Million USD) by Players (2016 and 2017)
Figure Malignant Lymphoma Market Size Share by Players in 2016
Figure Malignant Lymphoma Market Size Share by Players in 2017
Table Abbott Laboratories Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Abbott Laboratories (2012-2017)
Figure Abbott Laboratories Malignant Lymphoma Business Revenue Market Share in 2016
Table ABIOGEN PHARMA S.p.A Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of ABIOGEN PHARMA S.p.A (2012-2017)
Figure ABIOGEN PHARMA S.p.A Malignant Lymphoma Business Revenue Market Share in 2016
Table Actelion Pharmaceuticals Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Actelion Pharmaceuticals (2012-2017)
Figure Actelion Pharmaceuticals Malignant Lymphoma Business Revenue Market Share in 2016
Table Aeterna Zentaris Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Aeterna Zentaris (2012-2017)
Figure Aeterna Zentaris Malignant Lymphoma Business Revenue Market Share in 2016
Table Allos Therapeutics Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Allos Therapeutics (2012-2017)
Figure Allos Therapeutics Malignant Lymphoma Business Revenue Market Share in 2016
Table Astellas Pharma Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Astellas Pharma (2012-2017)
Figure Astellas Pharma Malignant Lymphoma Business Revenue Market Share in 2016
Table Bristol-Myers Squibb Company Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Bristol-Myers Squibb Company (2012-2017)
Figure Bristol-Myers Squibb Company Malignant Lymphoma Business Revenue Market Share in 2016
Table Celgene Corporation Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Celgene Corporation (2012-2017)
Figure Celgene Corporation Malignant Lymphoma Business Revenue Market Share in 2016
Table Eli Lilly and Company Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Eli Lilly and Company (2012-2017)
Figure Eli Lilly and Company Malignant Lymphoma Business Revenue Market Share in 2016
Table Genmab Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Genmab (2012-2017)
Figure Genmab Malignant Lymphoma Business Revenue Market Share in 2016
Table Inovio Pharmaceuticals Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Inovio Pharmaceuticals (2012-2017)
Figure Inovio Pharmaceuticals Malignant Lymphoma Business Revenue Market Share in 2016
Table Johnson & Johnson Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Johnson & Johnson (2012-2017)
Figure Johnson & Johnson Malignant Lymphoma Business Revenue Market Share in 2016
Table Merck & Co Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Merck & Co (2012-2017)
Figure Merck & Co Malignant Lymphoma Business Revenue Market Share in 2016
Table Novartis Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Novartis (2012-2017)
Figure Novartis Malignant Lymphoma Business Revenue Market Share in 2016
Table Onyx Pharmaceuticals Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Onyx Pharmaceuticals (2012-2017)
Figure Onyx Pharmaceuticals Malignant Lymphoma Business Revenue Market Share in 2016
Table Roche Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Roche (2012-2017)
Figure Roche Malignant Lymphoma Business Revenue Market Share in 2016
Table Seattle Genetics Basic Information List
Table Malignant Lymphoma Business Revenue (Million USD) of Seattle Genetics (2012-2017)
Figure Seattle Genetics Malignant Lymphoma Business Revenue Market Share in 2016
Table Global Malignant Lymphoma Market Size (Million USD) by Type (2012-2017)
Figure Global Malignant Lymphoma Market Size Share by Type in 2012
Figure Global Malignant Lymphoma Market Size Share by Type in 2013
Figure Global Malignant Lymphoma Market Size Share by Type in 2014
Figure Global Malignant Lymphoma Market Size Share by Type in 2015
Figure Global Malignant Lymphoma Market Size Share by Type in 2016
Figure Global Malignant Lymphoma Market Size Share by Type in 2017
Table Global Malignant Lymphoma Market Size (Million USD) by Application (2012-2017)
Figure Global Malignant Lymphoma Market Size (Million USD) by Application in 2012
Figure Global Malignant Lymphoma Market Size (Million USD) by Application in 2013
Figure Global Malignant Lymphoma Market Size (Million USD) by Application in 2014
Figure Global Malignant Lymphoma Market Size (Million USD) by Application in 2015
Figure Global Malignant Lymphoma Market Size (Million USD) by Application in 2016
Figure Global Malignant Lymphoma Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Malignant Lymphoma
Figure United States Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Malignant Lymphoma Market Size (Million USD) by Players (2012-2017)
Figure United States Malignant Lymphoma Market Size Share by Players in 2016
Figure United States Malignant Lymphoma Market Size Share by Players in 2017
Figure EU Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Malignant Lymphoma Market Size (Million USD) by Players (2012-2017)
Figure EU Malignant Lymphoma Market Size Share by Players in 2016
Figure EU Malignant Lymphoma Market Size Share by Players in 2017
Figure Japan Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Malignant Lymphoma Market Size (Million USD) by Players (2012-2017)
Figure Japan Malignant Lymphoma Market Size Share by Players in 2016
Figure Japan Malignant Lymphoma Market Size Share by Players in 2017
Figure China Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Malignant Lymphoma Market Size (Million USD) by Players (2012-2017)
Figure China Malignant Lymphoma Market Size Share by Players in 2016
Figure China Malignant Lymphoma Market Size Share by Players in 2017
Figure India Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Malignant Lymphoma Market Size (Million USD) by Players (2012-2017)
Figure India Malignant Lymphoma Market Size Share by Players in 2016
Figure India Malignant Lymphoma Market Size Share by Players in 2017
Figure Southeast Asia Malignant Lymphoma Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Malignant Lymphoma Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Malignant Lymphoma Market Size Share by Players in 2016
Figure Southeast Asia Malignant Lymphoma Market Size Share by Players in 2017
Figure Global Malignant Lymphoma Market Size (Million USD) by Regions (2017-2022)
Table Global Malignant Lymphoma Market Size (Million USD) by Regions (2017-2022)
Figure Global Malignant Lymphoma Market Size Share by Regions in 2017
Figure Global Malignant Lymphoma Market Size Share by Regions in 2022
Figure United States Malignant Lymphoma Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Malignant Lymphoma Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Malignant Lymphoma Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Malignant Lymphoma Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Malignant Lymphoma Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Malignant Lymphoma Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Malignant Lymphoma Market Size (Million USD) by Type (2017-2022)
Figure Global Malignant Lymphoma Market Size Share by Type in 2017
Figure Global Malignant Lymphoma Market Size Share by Type in 2022
Table Global Malignant Lymphoma Market Size (Million USD) by Application (2017-2022)
Figure Global Malignant Lymphoma Market Size (Million USD) by Application in 2017
Figure Global Malignant Lymphoma Market Size (Million USD) by Application in 2022